Eupraxia Pharmaceuticals INC. 6-K Filing
Ticker: EPRX · Form: 6-K · Filed: Nov 13, 2025 · CIK: 1581178
Sentiment: neutral
Filing Stats: 172 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2025-11-13 17:00:06
Filing Documents
- f6k_111325.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 16KB
- image.jpg (GRAPHIC) — 152KB
- image2.jpg (GRAPHIC) — 224KB
- 0001171843-25-007294.txt ( ) — 540KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. EUPRAXIA PHARMACEUTICALS INC. Date: November 13, 2025 By: /s/ Alex Rothwell Name: Alex Rothwell Title: Chief Financial Officer